Home Reimbursed medicines Lidocain
Lidocain — maximum prices and reimbursement
The CANAMED catalogue contains 86 medicines with the active substance Lidocain, from 7 manufacturers. Below you can see each entry with the brand name, the manufacturer, the maximum retail price and the prescription status — plus live pharmacy prices, where we track them.
In short: for the active substance Lidocain there are 86 authorised medicines in the CANAMED catalogue, with maximum retail prices between 7.36 and 195.13 RON, from 7 manufacturers. The reimbursement percentage depends on the CNAS sublist each product is placed on (A 90%, B 50%, C1/C2 100%, D 20%) and applies to the reference price, not to the shelf price. The maximum price is the legal cap — pharmacies may sell below it, so it is worth comparing the real price before you go. Latest import: 2026-11-03.
Data verified on from public sources (OpenStreetMap, chain websites, ANM/MS) — updated daily.
CANAMED catalogue
All medicines with Lidocain
Maximum retail price = the legal selling cap. Sorted by price, lowest first.
| Brand name | Manufacturer | Maximum price | Reimbursement | Prescription |
|---|---|---|---|---|
| XILINA 20 mg/ ml | ZENTIVA S.A. - ROMANIA | 7.36 RON | not reimbursed | PR |
| LIDOCAINA GRINDEKS 20 mg/ml | AS GRINDEKS - LETONIA | 28.46 RON | not reimbursed | PRF |
| LIDOCAIN 4,6 mg/doza | EGIS PHARMACEUTICALS PLC. - UNGARIA | 33.44 RON | not reimbursed | PRF |
| XILINA 10 mg/ml (vezi C01BB01) | ZENTIVA S.A. - ROMANIA | 33.52 RON | not reimbursed | PR |
| XILINA 10 mg/ml (vezi N01BB02) | ZENTIVA S.A. - ROMANIA | 33.52 RON | not reimbursed | PR |
| VERSATIS 700 mg | GRUNENTHAL GMBH - GERMANIA | 36.14 RON | not reimbursed | PRF |
| XILINA 40 mg/ ml | ZENTIVA S.A. - ROMANIA | 55.74 RON | not reimbursed | PR |
| VERSATIS 700 mg | GRUNENTHAL GMBH - GERMANIA | 132.45 RON | not reimbursed | PRF |
| LIDOCAINA KABI 10 mg/ml | LABESFAL-LAB. ALMIRO S.A. (FRESENIUS KABI GROUP) - PORTUGALIA | 183.60 RON | not reimbursed | PR |
| VERSATIS 700 mg | GRUNENTHAL GMBH - GERMANIA | 195.13 RON | not reimbursed | PRF |
| INSTILLIDO 20 mg/ml | KLOSTERFRAU BERLIN GMBH - GERMANIA | — | not reimbursed | PRF |
| INSTILLIDO 20 mg/ml | KLOSTERFRAU BERLIN GMBH - GERMANIA | — | not reimbursed | PRF |
| LIDOCAINA KABI 10 mg/ml | LABESFAL-LAB. ALMIRO S.A. (FRESENIUS KABI GROUP) - PORTUGALIA | — | not reimbursed | PR |
| LIDOCAINA KABI 10 mg/ml | LABESFAL-LAB. ALMIRO S.A. (FRESENIUS KABI GROUP) - PORTUGALIA | — | not reimbursed | PR |
| LIDOCAINA KABI 10 mg/ml | LABESFAL-LAB. ALMIRO S.A. (FRESENIUS KABI GROUP) - PORTUGALIA | — | not reimbursed | PR |
| LIDOCAINA KABI 10 mg/ml | LABESFAL-LAB. ALMIRO S.A. (FRESENIUS KABI GROUP) - PORTUGALIA | — | not reimbursed | PR |
| LIDOCAINA KABI 10 mg/ml | LABESFAL-LAB. ALMIRO S.A. (FRESENIUS KABI GROUP) - PORTUGALIA | — | not reimbursed | PR |
| LIDOCAINA KABI 10 mg/ml | LABESFAL-LAB. ALMIRO S.A. (FRESENIUS KABI GROUP) - PORTUGALIA | — | not reimbursed | PR |
| LIDOCAINA KABI 10 mg/ml | LABESFAL-LAB. ALMIRO S.A. (FRESENIUS KABI GROUP) - PORTUGALIA | — | not reimbursed | PR |
| LIDOCAINA KABI 10 mg/ml | LABESFAL-LAB. ALMIRO S.A. (FRESENIUS KABI GROUP) - PORTUGALIA | — | not reimbursed | PR |
| LIDOCAINA KABI 10 mg/ml | LABESFAL-LAB. ALMIRO S.A. (FRESENIUS KABI GROUP) - PORTUGALIA | — | not reimbursed | PR |
| LIDOCAINA KABI 10 mg/ml | LABESFAL-LAB. ALMIRO S.A. (FRESENIUS KABI GROUP) - PORTUGALIA | — | not reimbursed | PR |
| LIDOCAINA KABI 10 mg/ml | LABESFAL-LAB. ALMIRO S.A. (FRESENIUS KABI GROUP) - PORTUGALIA | — | not reimbursed | PR |
| LIDOCAINA KABI 10 mg/ml | LABESFAL-LAB. ALMIRO S.A. (FRESENIUS KABI GROUP) - PORTUGALIA | — | not reimbursed | PR |
| LIDOCAINA KABI 10 mg/ml | LABESFAL-LAB. ALMIRO S.A. (FRESENIUS KABI GROUP) - PORTUGALIA | — | not reimbursed | PR |
| LIDOCAINA KABI 10 mg/ml | LABESFAL-LAB. ALMIRO S.A. (FRESENIUS KABI GROUP) - PORTUGALIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 10 mg/ml | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 10 mg/ml | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 10 mg/ml | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 10 mg/ml | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 10 mg/ml | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 10 mg/ml | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 10 mg/ml | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 10 mg/ml | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 10 mg/ml | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 10 mg/ml | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 10 mg/ml | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 10 mg/ml | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 10 mg/ml | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 10 mg/ml | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 10 mg/ml | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 10 mg/ml | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 10 mg/ml | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 10 mg/ml | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 10 mg/ml | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 10 mg/ml | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 20 mg/ml (vezi N01BB02) | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 20 mg/ml (vezi N01BB02) | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 20 mg/ml (vezi N01BB02) | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 20 mg/ml (vezi N01BB02) | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 20 mg/ml (vezi N01BB02) | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 20 mg/ml (vezi N01BB02) | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 20 mg/ml (vezi N01BB02) | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 20 mg/ml (vezi N01BB02) | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 20 mg/ml (vezi N01BB02) | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 20 mg/ml (vezi N01BB02) | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 20 mg/ml (vezi N01BB02) | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 20 mg/ml (vezi N01BB02) | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 20 mg/ml (vezi N01BB02) | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 20 mg/ml (vezi N01BB02) | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 20 mg/ml (vezi N01BB02) | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 20 mg/ml (vezi N01BB02) | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 20 mg/ml (vezi N01BB02) | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 20 mg/ml (vezi N01BB02) | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 20 mg/ml (vezi N01BB02) | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIDOCAINA NORIDEM 20 mg/ml (vezi N01BB02) | DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA | — | not reimbursed | PR |
| LIVOHEP 10 mg/ml | AS GRINDEKS - LETONIA | — | not reimbursed | PRF |
| LIVOHEP 10 mg/ml | AS GRINDEKS - LETONIA | — | not reimbursed | PRF |
| LIVOHEP 10 mg/ml | AS GRINDEKS - LETONIA | — | not reimbursed | PRF |
| LIVOHEP 10 mg/ml | AS GRINDEKS - LETONIA | — | not reimbursed | PRF |
| LIVOHEP 10 mg/ml | AS GRINDEKS - LETONIA | — | not reimbursed | PRF |
| LIVOHEP 10 mg/ml | AS GRINDEKS - LETONIA | — | not reimbursed | PRF |
| LIVOHEP 20 mg/ml | AS GRINDEKS - LETONIA | — | not reimbursed | PRF |
| LIVOHEP 20 mg/ml | AS GRINDEKS - LETONIA | — | not reimbursed | PRF |
| LIVOHEP 20 mg/ml | AS GRINDEKS - LETONIA | — | not reimbursed | PRF |
| LIVOHEP 20 mg/ml | AS GRINDEKS - LETONIA | — | not reimbursed | PRF |
| LIVOHEP 20 mg/ml | AS GRINDEKS - LETONIA | — | not reimbursed | PRF |
| LIVOHEP 20 mg/ml | AS GRINDEKS - LETONIA | — | not reimbursed | PRF |
| LIVOHEP 20 mg/ml | AS GRINDEKS - LETONIA | — | not reimbursed | PRF |
| LIVOHEP 20 mg/ml | AS GRINDEKS - LETONIA | — | not reimbursed | PRF |
| VERSATIS 700 mg | GRUNENTHAL GMBH - GERMANIA | — | not reimbursed | PRF |
| VERSATIS 700 mg | GRUNENTHAL GMBH - GERMANIA | — | not reimbursed | PRF |
| XILINA 10 mg/ml (vezi C01BB01) | ZENTIVA S.A. - ROMANIA | — | not reimbursed | PR |
| XILINA 10 mg/ml (vezi N01BB02) | ZENTIVA S.A. - ROMANIA | — | not reimbursed | PR |
| XILINA 20 mg/ ml | ZENTIVA S.A. - ROMANIA | — | not reimbursed | PR |
| XILINA 40 mg/ ml | ZENTIVA S.A. - ROMANIA | — | not reimbursed | PR |
Prescription status key:
- PR — With a medical prescription (PR)
- PRF — With a medical prescription kept by the pharmacy (P-RF)
This catalogue does not record the reimbursement percentage per product. Reimbursement is set through the CNAS sublists — A 90%, B 50%, C1/C2 100%, D 20% of the reference price — see the full explanation of the sublists or ask the pharmacist for the exact placement.
Live pharmacy prices
Products with Lidocain in our comparator
Shelf prices collected from the large chains — see on each product page where it is cheapest.
Pharmacy prices for lidocain
Here you have the CANAMED maximum price and how much CNAS reimburses. What medicines with lidocain actually cost in online pharmacies, by chain, is at Lidocain — medicines and pharmacy prices.
Good to know
How to read the maximum price
The CANAMED maximum retail price is the legal cap approved by the Ministry of Health — the pharmacy may sell for less, never for more. If the medicine is reimbursed, the sublist percentage (A 90%, B 50%, C1/C2 100%, D 20%) applies to the reference price of the therapeutic group, usually calculated from the cheapest product with the same INN — which is why your contribution can differ from one brand to another, even for the same active substance. The electronic prescription automatically shows the exact amount to pay; for non-prescription shelf prices, use the HartaFarmacii comparator.
CANAMED catalogue
Other active substances in the catalogue
- Lenalidomid
- Lacosamid
- Levetiracetam
- Levofloxacin
- Levothyroxin
- Levocetirizin
- Losartan
- Lenvatinib
- Lamotrigin
- Letrozol
See also the full list of reimbursed medicines, with an alphabetical index of all active substances.
Frequently asked questions
FAQ · Lidocain
-
Is Lidocain reimbursed?
Reimbursement for Lidocain depends on the CNAS sublist the prescribed product is placed on (A 90%, B 50%, C1/C2 100%, D 20%) and on the reference price of the therapeutic group — not on the shelf price. The electronic prescription automatically shows the sublist and your contribution; ask the doctor or pharmacist for your exact situation. -
What is the CANAMED maximum price for Lidocain?
The maximum retail prices (the CANAMED legal cap) for medicines with Lidocain are between 7.36 and 195.13 RON. No pharmacy may sell above the maximum price, but it may sell below it — compare real prices with the HartaFarmacii comparator. -
What percentage of Lidocain is reimbursed?
The percentage depends on the CNAS sublist: A 90% (common chronic diseases), B 50% (partial reimbursement), C1 and C2 100% (serious chronic diseases and national programmes), D 20%. The percentage applies to the reference price set by CNAS, not to the shelf price, so you may pay a difference even for a “100% reimbursed” medicine. You can see the exact placement on the electronic prescription. -
How many medicines with Lidocain are in the CANAMED catalogue?
The CANAMED catalogue holds 86 authorised medicines with the active substance Lidocain — different brand names, strengths and pharmaceutical forms. You will find them all, with maximum price and prescription status, in the table on this page. Latest CANAMED import into the HartaFarmacii database: 2026-11-03.
Before you go